Evidence map›Paper›PMID 35491865›Full record

ArticleCell cycle (Georgetown, Tex.)2022

LINC00173 promotes Wilms' tumor progression through MGAT1-mediated MUC3A

Qingliang Zhu, Deming Zhan, Yongguo Yang, Yankun Chong, Haoliang Xue, Peng Zhu

Open access · greenAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Expression of Tumor SuppressorInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qingliang ZhuDepartment of Urology Surgery, Jiangdu People's Hospital of Yangzhou, Yangzhou, Jiangsu, China.
Deming ZhanDepartment of Urology Surgery, Jiangdu People's Hospital of Yangzhou, Yangzhou, Jiangsu, China.
Yongguo YangDepartment of Pathology, Jiangdu People's Hospital of Yangzhou, Yangzhou, Jiangsu, China.
Yankun ChongDepartment of Urology Surgery, Jiangdu People's Hospital of Yangzhou, Yangzhou, Jiangsu, China.
Haoliang XueDepartment of Urology Surgery, Jiangdu People's Hospital of Yangzhou, Yangzhou, Jiangsu, China.
Peng ZhuDepartment of Urology Surgery, Jiangdu People's Hospital of Yangzhou, Yangzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have unveiled that LINC00173 promotes small cell lung cancer progression. However, LINC00173 has not been studied in Wilms' tumor (WT).

Indexed as

Kidney NeoplasmsWilms TumorAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGlycosylationLINC00173MGAT1mRNA stabilityMUC3AN-glycosylationWilms’ tumor

Identifiers

PMID35491865
PMCPMC9359378
OpenAlexW4225246884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.